Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000315066-18-001012
Filing Date
2018-02-13
Accepted
2018-02-13 09:32:57
Documents
1

Document Format Files

Seq Description Document Type Size
1 filing.txt SC 13G/A 7226
  Complete submission text file 0000315066-18-001012.txt   8800
Mailing Address 245 SUMMER STREET BOSTON MA 02210
Business Address 245 SUMMER STREET BOSTON MA 02210 6175706339
FMR LLC (Filed by) CIK: 0000315066 (see all company filings)

EIN.: 043532603 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 0000

Mailing Address SUITE 400, 101 LINDENWOOD DRIVE MALVERN PA 19355
Business Address SUITE 400, 101 LINDENWOOD DRIVE MALVERN PA 19355 484-321-5554
Aclaris Therapeutics, Inc. (Subject) CIK: 0001557746 (see all company filings)

EIN.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89137 | Film No.: 18599511
SIC: 2834 Pharmaceutical Preparations